GILD insiders

17 insiders have filed at GILD since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
O'Day Daniel PatrickChairman & CEO642.6k0.051%22 sells $46.5M
Dickinson Andrew DChief Financial Officer179.2k0.014%25 sells $59.7M
Mercier JohannaChief Comm & Corp Aff Officer131.8k0.011%27 sells $21.5M
Parsey MerdadChief Medical Officer82.8k<0.01%14 sells $20.5M
Wilfong Diane E.Interim Corp Controller & CAO46.3k<0.01%
Telman Deborah HEVP, Corporate Affairs & Gc43.7k<0.01%3 sells $6.6M
Patterson SandraSVP, Controllership39.5k<0.01%
Barton Jacqueline KDirector26.1k<0.01%
Berger DietmarChief Medical Officer19.0k<0.01%
Manwani HarishDirector14.1k<0.01%
Rodriguez JavierDirector12.2k<0.01%
Welters AnthonyDirector11.7k<0.01%
Bluestone JeffreyDirector8.9k<0.01%4 sells $2.4M
Horning SandraDirector5.1k<0.01%
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp5.1k<0.01%
Love Ted WDirector4.3k<0.01%
Kramer Kelly A.Director1.3k<0.01%2 sells $713k

Full register at boothcheck.com/insiders/GILD. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

GILD institutional holders · GILD research report